Search

Your search keyword '"XIANG Mingyue"' showing total 25 results
Start Over Author "XIANG Mingyue"
25 results on '"XIANG Mingyue"'

1. Research and application progress of cold-chain logistics packaging technology of fresh agricultural products

Author

XIANG Mingyue

Subjects
fresh agricultural products, cold chain logistics, packing technology, Food processing and manufacture, TP368-456
Abstract

Cold chain logistics packaging technology is crucial for the operation of perishable food chains （such as meat, fish, dairy products, fruit and vegetable products） and certain products in the pharmaceutical industry （such as vaccines, biopharmaceuticals, and blood products）. In the future, the cold chain logistics packaging of fresh agricultural products will tend towards high-performance, environmentally friendly, and digital development. The article reviews the packaging technologies used in the cold chain logistics of fresh agricultural products in recent years. Analyzes the characteristics, use value, application scope, technical advantages and disadvantages of different packaging materials, and analyzes the potential cold chain logistics packaging technologies and materials for agricultural products, as well as the composite use of different packaging technologies, in order to explore the optimal packaging for different fresh agricultural products. Develop corresponding cold chain logistics packaging tailored to different fresh agricultural products, gradually abandoning packaging technologies with low recycling rates and poor performance. By increasing the frequency of recycling and reducing the cost of using high-performance materials, to reduce losses in the cold chain logistics of fresh agricultural products and achieve the goal of environmental friendliness.

Published
2023
Full Text
View/download PDF

3. Distributed Top-k Pattern Mining

Author

Wang, Xin, Xiang, Mingyue, Zhan, Huayi, Lan, Zhuo, He, Yuang, He, Yanxiao, Sha, Yuji, Goos, Gerhard, Founding Editor, Hartmanis, Juris, Founding Editor, Bertino, Elisa, Editorial Board Member, Gao, Wen, Editorial Board Member, Steffen, Bernhard, Editorial Board Member, Woeginger, Gerhard, Editorial Board Member, Yung, Moti, Editorial Board Member, U, Leong Hou, editor, Spaniol, Marc, editor, Sakurai, Yasushi, editor, and Chen, Junying, editor

Published
2021
Full Text
View/download PDF

6. Distributed Top-k Pattern Mining

Author

Wang, Xin, primary, Xiang, Mingyue, additional, Zhan, Huayi, additional, Lan, Zhuo, additional, He, Yuang, additional, He, Yanxiao, additional, and Sha, Yuji, additional

Published
2021
Full Text
View/download PDF

20. Induction Chemotherapy Followed by Chemoradiotherapy With or Without Consolidation Chemotherapy Versus Chemoradiotherapy Followed by Consolidation Chemotherapy for Esophageal Squamous Cell Carcinoma

Author

Xiang, Mingyue, Liu, Bo, Zhang, Guifang, Gong, Heyi, Han, Dali, and Ma, Changsheng

Subjects
Cancer Research, Oncology
Abstract

ObjectiveThis study aimed to compare the efficacy and safety of induction chemotherapy followed by concurrent chemoradiotherapy (I-CCRT), induction chemotherapy followed by concurrent chemoradiotherapy and consolidation chemotherapy (I-CCRT-C), and concurrent chemoradiotherapy followed by consolidation chemotherapy (CCRT-C) for locally advanced esophageal squamous cell carcinoma (ESSC).Patients and MethodsPatients with locally advanced ESCC who underwent definitive chemoradiotherapy with cisplatin plus fluorouracil or docetaxel from February 2012 to December 2018 were retrospectively reviewed. Kaplan–Meier curve was used to estimate survival. Efficacy was assessed using RECIST, version 1.0. Prognosis factors were identified with Cox regression analysis.ResultsPatients were treated with CCRT-C (n = 59), I-CCRT (n = 20), and I-CCRT-C (n = 48). The median follow-up duration was 73.9 months for the entire cohort. The ORR of the CCRT-C, I-CCRT, and I-CCRT-C groups was 89.8%, 70.0%, and 77.1%, respectively (p = 0.078). The median PFS in the CCRT-C, I-CCRT, and I-CCRT-C groups was 32.5, 16.1, and 27.1 months, respectively (p = 0.464). The median OS of the CCRT-C, I-CCRT, and I-CCRT-C groups was 45.9, 35.5, and 54.0 months, respectively (p = 0.788). Cox regression analysis indicated that I-CCRT-C and I-CCRT did not significantly prolong PFS and OS compared with CCRT-C (p > 0.05). Neutropenia grade ≥3 in CCRT-C, I-CCRT, and I-CCRT-C groups was 47.5%, 15%, and 33.3% of patients, respectively (p = 0.027).ConclusionsI-CCRT and I-CCRT-C using cisplatin plus fluorouracil or docetaxel regimen are not superior to CCRT-C in survival but seem to have less severe neutropenia than CCRT-C. Further randomized controlled studies are warranted.

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results